axicabtagene ciloleucel,fludarabine
gilead,daiichi sankyo,Bayer
['axi-cel', 'fludarabine']
#ash22
abstract 657 - et al. in patients receiving axi-cel, fludarabine underexposure was associated with higher risk of disease-related treatment failure while overexposure was associated with more toxicities. optimal fludarabine exposure may improve car t outcomes. 
Hematologist at Saint Antoine Hospital, Paris, France @Sorbonne_Univ_ @APHP. @JACIE_EBMT National Representative. #BMTsm #LYMsm #CARTcell #CardioOnc #QoL